Insiders · WGS

WGS insider transactions

GeneDx Holdings Corp. (WGS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

WGS insiders

Everyone who has filed a Form 3, 4, 5 or 144 at GeneDx Holdings Corp., latest first. Follow anyone to get their next filing.

• Katherine StuelandChief Executive Officer, Director, since April 2022+$100K-$38.8M
• Kevin FeeleyChief Financial Officer, since August 2022-$15.6M
• Thomas FuchsDirector, since September 2025
• Mark A GardnerPresident, since June 2026
• Jason RyanExecutive Chairman, Director, since July 2021+$161K-$8.33M
• Joshua RuchDirector, since July 2021-$6.09M
• Richard C Pfenniger JrDirector, since April 2022+$69.9K
• Keith A. MeisterDirector, 10% owner, since January 2022+$128M-$3.85M
• Emily M. LeproustDirector
• Eli CasdinDirector, 10% owner+$75.7M
• Casdin Capital, LLCDirector, 10% owner, since January 2023+$41.1M-$60.5M
• Bryan DechairoChief Operating Officer, since January 2025-$851K
• Casdin Partners Master Fund, L.P.Insider
• Icahn School Of Medicine At Mount Sinai10% owner, since July 2021+$35M-$75.3M
• Opko Health, Inc.10% owner, since April 2022+$5M-$29.7M
• Kareem SaadChief Transformation Officer, since July 2021-$260K
• Karen Ann WhiteOfficer, since July 2021-$57.3K
• Isaac RoOfficer, since July 2021-$727K
• Shawn AssadInsider, since July 2021-$52.1K
• Anthony PrenticeInsider-$27.4K
• Daniel Emmett ClarkInsider, since July 2021-$19.9K
• Rachel E. ShermanDirector, since July 2021
• Richard MiaoInsider, since June 2022-$7,057
• Corvex Management LPDirector, 10% owner, since January 2023
• Michael J PelliniDirector, since July 2021
• Eric SchadtOfficer, Director, since July 2021+$192K-$412K
• Nat TurnerDirector
• Blackstone Tactical Opportunities Associates III - NQ L.P.10% owner+$10M
• BTO Sema4 Holdings L.P.10% owner, since July 2021+$10M
• James CoffinOfficer, since July 2021-$43.4K
• Dennis CharneyDirector, since July 2021
• Blackstone Tactical Opportunities Fund - FD L.P.10% owner, since July 2021

Recent Form 3, 4, and 5 filings for WGS

• 51d
  CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 18,750 shares and sold $1,025,013 worth of shares (10,501 units at $97.61), increasing direct ownership by 8% to 115,476 units (SEC Form 4) (withholding obligation)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 51d
  CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 7,197 shares and sold $363,892 worth of shares (3,728 units at $97.61), increasing direct ownership by 8% to 44,945 units (SEC Form 4) (tax withholding)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 51d
  Director Fuchs Thomas converted options into 1,146 shares (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 58d
  CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 6,547 shares and sold $310,932 worth of shares (3,692 units at $84.22), increasing direct ownership by 3% to 107,227 units (SEC Form 4) to cover taxes

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 58d
  CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 2,462 shares and sold $108,220 worth of shares (1,285 units at $84.22), increasing direct ownership by 3% to 41,476 units (SEC Form 4) to satisfy tax liability

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 66d
  CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 717 shares and sold $31,188 worth of shares (372 units at $83.84), increasing direct ownership by 0.86% to 40,299 units (SEC Form 4) to cover taxes

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 130d
  SEC Form 4 filed by President Gardner Mark A

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 138d
  Director Ryan Jason converted options into 3,576 shares, increasing direct ownership by 30% to 15,480 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 138d
  Director Ruch Joshua converted options into 3,576 shares, increasing direct ownership by 12% to 33,299 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 138d
  Director Pfenniger Richard C Jr converted options into 3,576 shares, increasing direct ownership by 9% to 45,082 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 138d
  Director Meister Keith A. converted options into 3,576 shares, increasing direct ownership by 18% to 23,705 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 138d
  Director Leproust Emily M. converted options into 3,576 shares, increasing direct ownership by 17% to 24,852 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 138d
  SEC Form 4 filed by Director Fuchs Thomas

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 138d
  Director Casdin Eli converted options into 3,576 shares, increasing direct ownership by 17% to 24,093 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 143d
  CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 7,197 shares and sold $226,597 worth of shares (3,729 units at $60.77), increasing direct ownership by 10% to 39,954 units (SEC Form 4) (tax withholding)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 143d
  CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 18,750 shares and sold $638,104 worth of shares (10,501 units at $60.77), increasing direct ownership by 9% to 104,372 units (SEC Form 4) (withholding tax)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 145d
  SEC Form 3 filed by new insider Gardner Mark A

  3 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 153d
  Director Casdin Capital, Llc bought $11,109,565 worth of shares (200,000 units at $55.55) (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 158d
  CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 717 shares and sold $19,092 worth of shares (369 units at $51.74), increasing direct ownership by 1.00% to 35,290 units (SEC Form 4) to cover taxes

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 171d
  Director Casdin Capital, Llc bought $21,459,736 worth of shares (500,000 units at $42.92) (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 176d
  Director Meister Keith A. bought $13,765,345 worth of shares (351,273 units at $39.19) (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 180d
  Director Meister Keith A. bought $46,806,729 worth of shares (1,205,147 units at $38.84) (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 180d
  SEC Form 4 filed by Director Casdin Capital, Llc

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 191d
  CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 3,874 shares and sold $141,595 worth of shares (2,172 units at $65.19), increasing direct ownership by 2% to 93,216 units (SEC Form 4) (for tax liability)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 191d
  CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 754 shares and sold $25,555 worth of shares (392 units at $65.19), increasing direct ownership by 1% to 34,942 units (SEC Form 4) to satisfy withholding tax

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 222d
  SEC Form 4 filed by Feeley Kevin

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 223d
  SEC Form 4 filed by Stueland Katherine

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 235d
  CHIEF EXECUTIVE OFFICER Stueland Katherine sold $1,319,291 worth of shares (17,179 units at $76.80) and converted options into 30,671 shares, increasing direct ownership by 30% to 58,447 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 235d
  CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 11,012 shares and sold $438,203 worth of shares (5,706 units at $76.80), increasing direct ownership by 24% to 27,148 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 242d
  SEC Form 4 filed by GeneDx Holdings Corp.

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 242d
  SEC Form 4 filed by GeneDx Holdings Corp.

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 244d
  CHIEF FINANCIAL OFFICER Feeley Kevin was granted 1,986 shares, increasing direct ownership by 11% to 20,660 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 244d
  CHIEF EXECUTIVE OFFICER Stueland Katherine was granted 3,404 shares, increasing direct ownership by 9% to 42,087 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 247d
  Director Meister Keith A. bought $13,460,090 worth of shares (169,521 units at $79.40) (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 247d
  SEC Form 4 filed by Chief Operating Officer Dechairo Bryan

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 247d
  CHIEF FINANCIAL OFFICER Feeley Kevin was granted 15,262 shares and sold $486,370 worth of shares (6,187 units at $78.61), increasing direct ownership by 95% to 18,674 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 247d
  CHIEF EXECUTIVE OFFICER Stueland Katherine was granted 47,684 shares and sold $2,001,371 worth of shares (25,459 units at $78.61), increasing direct ownership by 135% to 38,683 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 249d
  CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 718 shares and sold $22,248 worth of shares (287 units at $77.52), increasing direct ownership by 5% to 9,599 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 275d
  Chief Operating Officer Dechairo Bryan sold $510,874 worth of shares (5,961 units at $85.70), closing all direct ownership in the company (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 277d
  Chief Operating Officer Dechairo Bryan converted options into 9,374 shares and sold $339,682 worth of shares (3,413 units at $99.53) (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 279d
  CHIEF FINANCIAL OFFICER Feeley Kevin sold $29,794 worth of shares (317 units at $93.99) and converted options into 754 shares, increasing direct ownership by 5% to 9,168 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 279d
  CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 3,874 shares and sold $155,375 worth of shares (1,653 units at $94.00), increasing direct ownership by 16% to 16,458 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 324d
  CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 7,197 shares and sold $554,616 worth of shares (3,855 units at $143.87), increasing direct ownership by 62% to 8,731 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 324d
  CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 18,750 shares and sold $1,562,185 worth of shares (10,857 units at $143.89), increasing direct ownership by 124% to 14,237 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 332d
  CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 2,462 shares and sold $201,648 worth of shares (1,266 units at $159.28), increasing direct ownership by 29% to 5,389 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 332d
  CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 6,547 shares and sold $579,620 worth of shares (3,639 units at $159.28), increasing direct ownership by 85% to 6,344 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 340d
  CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 717 shares and sold $61,276 worth of shares (377 units at $162.54), increasing direct ownership by 9% to 4,193 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 347d
  Director Ruch Joshua sold $6,093,967 worth of shares (38,000 units at $160.37) (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 373d
  CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 3,874 shares and sold $294,654 worth of shares (2,158 units at $136.54), increasing direct ownership by 100% to 3,436 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 373d
  CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 753 shares and sold $52,978 worth of shares (388 units at $136.54), increasing direct ownership by 11% to 3,757 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 398d
  Amendment: SEC Form 4 filed by Director Meister Keith A.

  4/A - GeneDx Holdings Corp. (0001818331) (Issuer)
• 403d
  CHIEF EXECUTIVE OFFICER Stueland Katherine sold $1,390,911 worth of shares (12,858 units at $108.17), decreasing direct ownership by 88% to 1,720 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 403d
  CHIEF FINANCIAL OFFICER Feeley Kevin exercised 1,246 shares at a strike of $32.67 and sold $716,261 worth of shares (6,609 units at $108.38), decreasing direct ownership by 61% to 3,392 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 415d
  SEC Form 4 filed by Director Fuchs Thomas

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 415d
  SEC Form 3 filed by new insider Fuchs Thomas

  3 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 415d
  Amendment: CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 7,197 shares, increasing direct ownership by 136% to 12,483 units (SEC Form 4)

  4/A - GeneDx Holdings Corp. (0001818331) (Issuer)
• 415d
  CHIEF FINANCIAL OFFICER Feeley Kevin sold $452,850 worth of shares (3,728 units at $121.47), decreasing direct ownership by 56% to 8,755 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 415d
  CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 18,750 shares and sold $1,275,585 worth of shares (10,501 units at $121.47), increasing direct ownership by 130% to 14,578 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 423d
  Chief Executive Officer Stueland Katherine sold $468,297 worth of shares (3,657 units at $128.06) and converted options into 6,546 shares, increasing direct ownership by 84% to 6,329 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)
• 423d
  CHIEF FINANCIAL OFFICER Feeley Kevin sold $162,886 worth of shares (1,272 units at $128.05) and converted options into 2,462 shares, increasing direct ownership by 29% to 5,286 units (SEC Form 4)

  4 - GeneDx Holdings Corp. (0001818331) (Issuer)